National Health Investors (NYSE:NHI) Downgraded by Bank of America to “Underperform”

National Health Investors (NYSE:NHI) was downgraded by Bank of America from a “buy” rating to an “underperform” rating in a research note issued to investors on Friday, FinViz reports. They presently have a $67.00 price target on the real estate investment trust’s stock, down from their prior price target of $86.00. Bank of America‘s target price would suggest a potential upside of 3.60% from the company’s previous close.

A number of other research analysts have also recently weighed in on the stock. Truist Financial lowered their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, September 2nd. Weiss Ratings lowered National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. Wells Fargo & Company decreased their price target on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. BMO Capital Markets restated an “outperform” rating on shares of National Health Investors in a research report on Wednesday, September 23rd. Finally, Zacks Research raised National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, National Health Investors currently has an average rating of “Moderate Buy” and an average target price of $79.44.

National Health Investors Stock Performance

Shares of NHI opened at $64.67 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 6.78. National Health Investors has a one year low of $63.51 and a one year high of $91.38. The firm has a market capitalization of $3.18 billion, a P/E ratio of 4.54, a PEG ratio of 4.21 and a beta of 0.51. The business has a fifty day moving average of $67.48 and a 200 day moving average of $75.93.

National Health Investors (NYSE:NHI) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $10.29. The business had revenue of $113.48 million during the quarter, compared to analysts’ expectations of $68.53 million. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. As a group, sell-side analysts anticipate that National Health Investors will post 4.76 EPS for the current year.

Hedge Funds Weigh In On National Health Investors

Several institutional investors have recently bought and sold shares of the stock. Deutsche Bank AG purchased a new stake in National Health Investors in the 2nd quarter worth $9,252,000. Bank of America Corp DE bought a new position in shares of National Health Investors during the 2nd quarter valued at about $77,738,000. Forty three Eighteen Advisors LLC purchased a new position in shares of National Health Investors during the first quarter valued at about $2,005,000. Public Employees Retirement System of Ohio purchased a new position in shares of National Health Investors during the second quarter valued at about $4,243,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of National Health Investors during the second quarter valued at about $1,870,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about National Health Investors

These are some of the NHI headlines that stood out recently:

• Positive Sentiment: Huntington initiated coverage with a “Strong Buy” rating and forecasts EPS rising from $4.76 in 2026 to $5.00 in 2027 and $5.27 in 2028. Its 2026 estimate is modestly above the cited $4.69 consensus, while the longer-term projections point to expected earnings growth. Huntington rating
• Neutral Sentiment: NHI’s Q3 FFO of $1.12 per share matched FactSet expectations, indicating results were in line rather than a surprise catalyst. Q3 FFO results
• Negative Sentiment: Some operating partners are dealing with community transitions and a muted summer selling season. These challenges could create uncertainty around property operations and growth, tempering the positive analyst outlook. Operating partner challenges

About National Health Investors

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.